BIOMAT Database Logo BIOMAT Database Logo

Serum immunosuppressive acidic protein as a potent prognostic factor for patients with metastatic renal cell carcinoma. 2001

T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Department of Urology, Chiba University School of Medicine, Japan. tigaras@med.m.chiba-u.ac.jp

BACKGROUND Estimation of survival probability of individual patients with metastatic renal cell carcinoma was difficult owing to diverse prognostic factors. We analyzed serum immunosuppressive acidic protein (IAP) levels and the cutoff value, then tested its validity for assessing patients' prognoses. METHODS Serum IAP was measured longitudinally in 84 patients with metastatic disease. Before therapy, cutoff levels of IAP were tested every 20 microg/ml between 600 and 1200 microg/ml. The prognostic importance of IAP and its cutoff level was estimated. RESULTS The cutoff level of IAP was set at 800 microg/ml for 40 patients who had metastatic disease with the primary tumor in situ and for 44 patients with recurrent disease. IAP was found to be a significant prognostic factor for both patient groups. CONCLUSIONS Serum IAP is an important prognostic factor for patients with metastatic renal cell carcinoma. Stratification of patients according to prognosis is feasible using the cutoff level.

UI MeSH Term Description Entries
D007680 Kidney Neoplasms Tumors or cancers of the KIDNEY. Cancer of Kidney,Kidney Cancer,Renal Cancer,Cancer of the Kidney,Neoplasms, Kidney,Renal Neoplasms,Cancer, Kidney,Cancer, Renal,Cancers, Kidney,Cancers, Renal,Kidney Cancers,Kidney Neoplasm,Neoplasm, Kidney,Neoplasm, Renal,Neoplasms, Renal,Renal Cancers,Renal Neoplasm
D008137 Longitudinal Studies Studies in which variables relating to an individual or group of individuals are assessed over a period of time. Bogalusa Heart Study,California Teachers Study,Framingham Heart Study,Jackson Heart Study,Longitudinal Survey,Tuskegee Syphilis Study,Bogalusa Heart Studies,California Teachers Studies,Framingham Heart Studies,Heart Studies, Bogalusa,Heart Studies, Framingham,Heart Studies, Jackson,Heart Study, Bogalusa,Heart Study, Framingham,Heart Study, Jackson,Jackson Heart Studies,Longitudinal Study,Longitudinal Surveys,Studies, Bogalusa Heart,Studies, California Teachers,Studies, Jackson Heart,Studies, Longitudinal,Study, Bogalusa Heart,Study, California Teachers,Study, Longitudinal,Survey, Longitudinal,Surveys, Longitudinal,Syphilis Studies, Tuskegee,Syphilis Study, Tuskegee,Teachers Studies, California,Teachers Study, California,Tuskegee Syphilis Studies
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009362 Neoplasm Metastasis The transfer of a neoplasm from one organ or part of the body to another remote from the primary site. Metastase,Metastasis,Metastases, Neoplasm,Metastasis, Neoplasm,Neoplasm Metastases,Metastases
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D011379 Prognosis A prediction of the probable outcome of a disease based on a individual's condition and the usual course of the disease as seen in similar situations. Prognostic Factor,Prognostic Factors,Factor, Prognostic,Factors, Prognostic,Prognoses
D002292 Carcinoma, Renal Cell A heterogeneous group of sporadic or hereditary carcinoma derived from cells of the KIDNEYS. There are several subtypes including the clear cells, the papillary, the chromophobe, the collecting duct, the spindle cells (sarcomatoid), or mixed cell-type carcinoma. Adenocarcinoma, Renal Cell,Carcinoma, Hypernephroid,Grawitz Tumor,Hypernephroma,Renal Carcinoma,Adenocarcinoma Of Kidney,Adenocarcinoma, Renal,Chromophil Renal Cell Carcinoma,Chromophobe Renal Cell Carcinoma,Clear Cell Renal Carcinoma,Clear Cell Renal Cell Carcinoma,Collecting Duct Carcinoma,Collecting Duct Carcinoma (Kidney),Collecting Duct Carcinoma of the Kidney,Nephroid Carcinoma,Papillary Renal Cell Carcinoma,Renal Cell Cancer,Renal Cell Carcinoma,Renal Cell Carcinoma, Papillary,Renal Collecting Duct Carcinoma,Sarcomatoid Renal Cell Carcinoma,Adenocarcinoma Of Kidneys,Adenocarcinomas, Renal Cell,Cancer, Renal Cell,Carcinoma, Collecting Duct,Carcinoma, Collecting Duct (Kidney),Carcinoma, Nephroid,Carcinoma, Renal,Carcinomas, Collecting Duct,Carcinomas, Collecting Duct (Kidney),Carcinomas, Renal Cell,Collecting Duct Carcinomas,Collecting Duct Carcinomas (Kidney),Hypernephroid Carcinoma,Hypernephroid Carcinomas,Hypernephromas,Kidney, Adenocarcinoma Of,Nephroid Carcinomas,Renal Adenocarcinoma,Renal Adenocarcinomas,Renal Carcinomas,Renal Cell Adenocarcinoma,Renal Cell Adenocarcinomas,Renal Cell Cancers,Renal Cell Carcinomas,Tumor, Grawitz
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
[Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
May 2002, Nihon Hinyokika Gakkai zasshi. The japanese journal of urology,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
January 1991, European urology,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Serum immunosuppressive acidic protein in renal cell carcinoma.
January 1986, Urological research,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
September 2000, The Journal of urology,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Prognostic value of preoperative serum immunosuppressive acidic protein in patients with esophageal squamous cell carcinoma.
January 2003, Diseases of the esophagus : official journal of the International Society for Diseases of the Esophagus,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Serum level of immunosuppressive acidic protein in haemodialysis patients with or without renal cell carcinoma.
April 1994, British journal of urology,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Thrombocytosis as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
October 2006, Cancer,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Hypercoagulability as a prognostic factor for survival in patients with metastatic renal cell carcinoma.
March 2009, Journal of experimental & clinical cancer research : CR,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
[Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
May 1991, Hinyokika kiyo. Acta urologica Japonica,
T Igarashi, and T Tobe, and H Kuramochi, and K Akakura, and T Ichikawa, and S Hamano, and N Suzuki, and Y Furuya, and H Ito
Changes in serum immunosuppressive acidic protein following surgery in patients with renal carcinoma.
October 1993, British journal of urology,
Copied contents to your clipboard!